Yarbrough Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,203
| Closed | -$37.1K | – | 214 |
|
|
2024
Q4 | $37.1K | Hold |
12,203
| – | – | ﹤0.01% | 190 |
|
|
2024
Q3 | $63.3K | Hold |
12,203
| – | – | ﹤0.01% | 200 |
|
|
2024
Q2 | $31.4K | Hold |
12,203
| – | – | ﹤0.01% | 197 |
|
|
2024
Q1 | $60K | Hold |
12,203
| – | – | ﹤0.01% | 195 |
|
|
2023
Q4 | $107K | Hold |
12,203
| – | – | 0.01% | 202 |
|
|
2023
Q3 | $140K | Hold |
12,203
| – | – | 0.01% | 200 |
|
|
2023
Q2 | $309K | Hold |
12,203
| – | – | 0.02% | 177 |
|
|
2023
Q1 | $393K | Buy |
+12,203
| New | +$393K | 0.03% | 147 |
|